A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1998

Conditions
HIV Infections
Interventions
DRUG

Amprenavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (15)

10016

NY Univ. HIV/AIDS CRS, New York

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

30308

The Ponce de Leon Ctr. CRS, Atlanta

35294

Alabama Therapeutics CRS, Birmingham

60611

Northwestern University CRS, Chicago

60612

Cook County Hosp. CORE Ctr., Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

63112

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

80262

University of Colorado Hospital CRS, Aurora

275997215

Unc Aids Crs, Chapel Hill

331361013

Univ. of Miami AIDS CRS, Miami

900331079

USC CRS, Los Angeles

02118

Bmc Actg Crs, Boston

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Unknown

Washington U CRS, St Louis

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH